Combined chemotherapy and radiation therapy for cervical cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 2, Issue 6, 2004, Pages 631-635

  Moore, David H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; Chemotherapy; Phase III trials; Radiation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; HYDROXYUREA; MITOMYCIN; NITROIMIDAZOLE DERIVATIVE;

EVALUATION; FEMALE; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PHASE 3 CLINICAL TRIAL; REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CISPLATIN; CLINICAL TRIALS, PHASE III AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; HYDROXYUREA; MITOMYCIN; NITROIMIDAZOLES; UTERINE CERVICAL NEOPLASMS;

EID: 38949099905     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2004.0052     Document Type: Article

References (29)

1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Fu KK. Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 1985;55: 2123-2130.
3. Sinclair WK. Hydroxyurea: Effects on Chinese hamster cells grown in culture. Cancer Res 1967;27:297-308.
4. Phillips RA, Tolmach LJ. Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat Res 1966;29:413-432.
5. Piver MS, Barlow JJ, Vongtama V, Blumenson L. Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervix. Am J Obstet Gynecol 1983;147:803-808.
6. Hreshchyshyn MM, Aron BS, Boronow RC, et al. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 1979;5:317-322.
7. Berry RJ. Effects of some metabolic inhibitors on x-ray doseresponse curves for the survival of mammalian cells in vitro, and on early recovery between fractionated x-ray doses. Br J Radiol 1966;39:458-463.
8. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x rays. Int J Radiat Oncol Biol Phys 1982;8: 1923-1933.
9. Kennedy KA, Rockwell S, Sartorelli AC. Enhancement of mitomycin-C cytotoxic metabolites by hypoxic tumor cells. Cancer Res 1980;40:2356-2360.
10. Thomas G, Dembo A, Fyles A, et al. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 1990;38:446-451.
11. Stehman FB, Bundy BN, Keys H, et al. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix: A preliminary report of a Gynecologic Oncology Group study. Am J Obstet Gynecol 1988;159:87-94.
12. Stehman FB, Bundy BN, Thomas G, et al. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Longterm follow-up of a Gynecologic Oncology Group trial. J Clin Oncol 1993;11:1523-1528.
13. Dische S, Chassagne D, Machin D. Randomized controlled trial of the use of pimonidazole (Ro 03 8799) in the treatment of advanced carcinoma of the cervix. In: Seventh International Conference on Chemical Modifiers of Cancer Treatment. Clearwater, FL; 1991:172-173.
14. Leibel S, Bauer M, Wasserman T, et al. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial. Int J Radiat Oncol Biol Phys 1987;13: 541-549.
15. Butler J, Hoey Bm, Swallow AJ. The radiation chemistry of some platinum-containing radiosensitizers and related compounds. Radiat Res 1985;102:1-13.
16. Nias AHW. Radiation and platinum drug interactions. Int J Radiat Biol 1985;48:297-314.
17. Begg AC, Van Der Kolk PJ, Dewit L, Bartelink H. Radiosensitization by cisplatin of RIF1 tumour cells in vitro. Int J Radiat Biol 1986;50:871-884.
18. Potish R, Twiggs L, Adcock L, et al. Effect of cisplatinum on tolerance to radiation therapy in advanced cervical cancer. Am J Clin Oncol 1986;9:387-391.
19. Malfetano J, Keys H, Kredentser D, et al. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 1993;71:3703-3706.
20. Runowicz CD, Wadler S, Rodriguez-Rodriguez L, et al. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol 1989;34:395-401.
21. Choo YC, Choy TK, Wong LC, Ma HK. Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma. Gynecol Oncol 1986;23: 94-100.
22. Whitney CW, Sause W, Bundy BN, et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-1348.
23. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: A randomized Radiation Therapy Oncology Group clinical trial. N Engl J Med 1999;340:1137-1143.
24. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin based radiotherapy and chemotherapy for locally-advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
25. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161.
26. Peters WA III, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613.
27. Clinical Announcement. National Cancer Institute. Concurrent chemoradiation for cervical cancer. U. S. Department of Health and Human Services, Public Health Service, National Institutes of Health; February, 1999. Available at: http://www.cancer.gov/clinicaltrials/developments/exerpt- announcement0300. Accessed September 2004.
28. Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002;20:966-972.
29. Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-1536.